Skip to main content

Day: May 2, 2024

Where Food Comes From, Inc. Reports 2024 First Quarter Financial Results

First Quarter Highlights – 2024 vs. 2023 Verification and certification revenue up 17% to $4.4 million from $3.8 million Product sales lower at $0.7 million vs. $1.0 million Total revenue increased to $5.6 million from $5.3 million Net income increased 47% to $178,000 from $121,000 Diluted EPS increased to $0.03 from $0.02 Adjusted EBITDA up 8% to $432,000 from $399,000 Company bought back 116,072 shares of its common stock in Q1 at cost of $1.5 million CASTLE ROCK, Colo., May 02, 2024 (GLOBE NEWSWIRE) — Where Food Comes From, Inc. (WFCF) (Nasdaq: WFCF), the most trusted resource for independent, third-party verification of food production practices in North America, today announced financial results for its first quarter ended March 31, 2024. “Despite the lingering impact of drought conditions resulting in smaller...

Continue reading

HomeTrust Bank Awarded Newsweek’s Most Loved Workplace Certification

ASHEVILLE, N.C., May 02, 2024 (GLOBE NEWSWIRE) — HomeTrust Bancshares, Inc. (NASDAQ: HTBI) (“Company”), the holding company of HomeTrust Bank (“Bank” or “HTB”), today announced that the Bank received a coveted Most Loved Workplace 2024 certification by Newsweek. Created in partnership with the Best Practices Institute, the annual ranking pays tribute to companies that put respect, caring and appreciation for employees at the center of their business model. “We are extremely proud to have HTB recognized by this distinguished certification,” said C. Hunter Westbrook, President & Chief Executive Officer. “Our team has intentionally worked on developing a behavioral-based culture that prioritizes two-way communication, a sense of belonging, opportunities for personal and professional growth, and benefits which support a strong...

Continue reading

Minera IRL Provides Bi-Weekly Default Status Report

LIMA, Peru, May 02, 2024 (GLOBE NEWSWIRE) — Minera IRL Limited (“Minera” or, the “Company”) (BVL:MIRL) (CSE:MIRL) (FWB:DZX) (OTCQB:MRLLF) is providing this default status report in accordance with National Policy 12-203 — Management Cease Trade Orders (“NP 12-203”) and the terms of a Management Cease Trade Order (“MCTO”) entered by the British Columbia Securities Commission (the “BCSC”) on April 3, 2024. The MCTO was entered against the Company’s Chief Executive Officer and its Interim Chief Financial Officer because the Company failed to file its annual audited financial statements, management’s discussion and analysis, annual information form and the required certifications (the “Annual Filings”) on or before April 2, 2024, as required by National Instrument 51-102, Continuous Disclosure Obligations, and National Instrument 52-109,...

Continue reading

Silvercrest Expands International and Global Equity Capability With Rehan Chaudhri, James A. Dunn, Jr., Ken Dennig, and Robert Gondolfo

NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) — Silvercrest Asset Management Group Inc. (NASDAQ:SAMG) is pleased to announce the hiring of Rehan Chaudhri, James A. Dunn, Jr., Ken Dennig, and Robert Gondolfo to enhance the firm’s investment capabilities and global outreach. The team will expand upon Silvercrest’s comprehensive investment capabilities with their Global Equity Strategy, broadening the firm’s offerings to families and institutional investors. Richard Hough, Chairman and Chief Executive Officer of Silvercrest, remarked, “The team brings significant investment expertise, a proven track record, and experience managing equity mandates on behalf of large institutions around the world. Rehan and his team deepen the firm’s intellectual capital in the International and Global space and complement Silvercrest’s existing International...

Continue reading

Elis: General shareholders meeting 23 may 2024 – Availability of documents

General shareholders’ meeting to be held on May 23, 2024Availability of the documents relating to the general shareholders’ meeting Saint-Cloud, 2 May 2024 – The Combined General Shareholders’ Meeting of Elis will be held on May 23, 2024, at 3pm at the Maison des Travaux Publics, 3 rue de Berri, 75008 Paris. The General Meeting will be held in the physical presence of the shareholders; it will not be retransmitted on the company’s website. Holders of bearer shares should ask their financial intermediaries for proxy or distance voting forms. Holders of registered shares will directly receive these forms together with their convening notice. The corresponding notice of meeting that contains the agenda, the draft text of the resolutions to be submitted to the vote of the shareholders and the terms and conditions to participate and vote to...

Continue reading

Team Member Feedback Earns HealthEquity Workplace Culture Recognition

For the fourth consecutive year, team members’ feedback has propelled HealthEquity to be recognized for cultural excellence DRAPER, Utah, May 02, 2024 (GLOBE NEWSWIRE) — HealthEquity, Inc. (NASDAQ: HQY), the nation’s largest Health Savings Account (HSA) custodian has received a Culture Excellence Award by Top Workplaces for the fourth consecutive year. “Our teammates deserve all the credit when it comes to this award,” said Cheryl King, executive vice president and chief human resource officer. “They have embraced our values and strive to bring our mission to life each day. Together, we’re making big things happen. We know if we can create the best working environment for our teammates, we’ll create the best experience for our partners, clients, and members.” The Top Workplaces Culture Excellence Award utilizes...

Continue reading

Kforce Inc. Announces its Participation at the Baird 2024 Global Consumer, Technology and Services Conference

TAMPA, Fla., May 02, 2024 (GLOBE NEWSWIRE) — Kforce Inc. (NASDAQ: KFRC), a solutions firm that specializes in technology and professional staffing services, today announced that management will participate at Baird’s Global Consumer, Technology, and Services Conference on June 5, 2024, in New York City. A link to the webcast and presentation, which is currently scheduled for 4:20pm, can be accessed at www.kforce.com under “Events and Presentations.” A replay of the webcast will be available for three months following the presentation. About Kforce Inc.Kforce is a solutions firm specializing in technology, finance and accounting, and professional staffing services. Our KNOWLEDGEforce® empowers industry-leading companies to achieve their digital transformation goals. We curate teams of technical experts who build solutions custom-tailored...

Continue reading

Information on share capital and voting rights – April 2024

Information on share capital and voting rights April 2024 Statement made in accordance with article L. 233-8 II of the French commercial Code and articles 221-1 2 ° f) and 223-16 of the AMF Regulations.                          May 2nd, 2024   Statement made by:         Nexans S.A.Registered office : 4 Allée de l’Arche – 92400 CourbevoieRCS Nanterre 393 525 852Regulated market of Euronext Paris (Compartment A) Date   Total number of shares   Total number of voting rights Theorical (1) Exercisable (2) April 30th, 2024 43,753,380 43,753,380 43,486,473 (1)   Calculated based on all shares with voting rights, including treasury shares stripped of voting rights (Art. 223-11 of AMF General Regulations). (2)    For information, excluding treasury shares stripped of voting rights, excluding...

Continue reading

Virios Therapeutics to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

ATLANTA, May 02, 2024 (GLOBE NEWSWIRE) — Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibromyalgia (“FM”) and Long-COVID (“LC”), announced today that it will report first quarter 2024 financial results on Thursday, May 9, 2024 before the open of the financial markets. Management will also host a webcast and conference call on May 9, 2024 at 8:30 a.m. ET to discuss the results and provide a corporate update. The live and archived webcast of the call may be accessed on the Virios Therapeutics website under the Investors section: Events and Presentations. The live call can be accessed by dialing 888-506-0062 (domestic) or 973-528-0011 (international) and asking to be connected to the...

Continue reading

Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer and Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

New role enhances company’s strong leadership team and solidifies commitment to ongoing clinical innovation DOYLESTOWN, Pa., May 02, 2024 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality, today announced the appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer (CMO) of the Company, effective May 1, 2024. Dr. Mirza has been an integral part of the Company’s senior team as a consultant since February, 2023 and will now assume a more central role in leading the Company’s development of its expanding clinical pipeline. “Aprea is at a critical point of enriching and expanding its clinical programs. Dr. Mirza has already made significant contributions to Aprea and we...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.